Staff, Cleveland Clinic Taussig Cancer Institute
Oncology
Dr. Sudipto Mukherjee, MD
|
|
Give Review
Doctor Sudipto Mukherjee, MD works in the field of Oncology. He researched medicine at NRS Medical College Calcutta. Dr. Sudipto Mukherjee is a published doctor and has 18 publications published. The lastest was: 'Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy.' Sudipto Mukherjee is registered with Medicare and accepts Medicare payments.
Publications
- Cost-effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy.
- Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy.
- Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Lingering Uncertainties and Emerging Possibilities.
- More is better: combination therapies for myelodysplastic syndromes.
- Is the cure the poison? The evolving story of therapy-related myeloid malignancies.
- Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemia.
- Resuscitating a dying marrow: the role of hematopoietic growth factors.
- Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.
- Predictive Factors for Latency Period and a Prognostic Model for Survival in Patients with Therapy-related AML.
- Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
- What's all the fuss about? facts and figures about bone marrow failure and conditions.
- Blood consult: treating del(5q) myelodysplastic syndromes.
- Anemia management with darbepoetin-alfa in outpatient hemodialysis patients switched from epoetin-alfa: a community hospital experience.
- Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature.
- Phenotype-associated changes in retinal pigment epithelial cell expression of insulin-like growth factor binding proteins.
- The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation.
- Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma.
Doctors Specialties
- Internal Medicine
- Oncology
Accepted Insurances
Education
-
Cleveland Clinic Foundation -
William Beaumont Hospital -
NRS Medical College Calcutta
Hospital
-
Cleveland Clinic
Helpful Reviews
Similar Doctors
|
|
Dr. Robert S. Kunkel Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hashem Attaran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maung T. Hlaing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ifijen M. Oleghe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manji B. Osifeso, MD |
|
|
Dr. Charles J. Nock, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alberto J. Montero, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alok A. Khorana, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Matthew M. Cooney, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Cheng E. Chee, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|